Newsletter Archive
-
07.17.24 -- Amgen Launches Novel Rare Disease Trial With New Organ-Specific Flare Definitions
7/17/2024
07/17/24 Clinical Leader Newsletter
-
07.17.24 -- Pioneering Patient-Centered Strategies And Innovative Pathways In Gene Therapy
7/17/2024
07/17/24 Clinical Leader Newsletter
-
07.16.24 -- Choosing The Right eTMF Platform: 3 Key Tips For Success
7/16/2024
07/16/24 Clinical Leader Newsletter
-
07.15.24 -- Insights From CISCRP Patient Survey: Addressing Diversity Gaps
7/15/2024
07/15/24 Clinical Leader Newsletter
-
07.12.24 -- Insights Into TMF Challenges And Solutions — Part 2
7/12/2024
07/12/24 Clinical Leader Newsletter
-
07.11.24 -- Getting A Grasp On CRO Selection
7/11/2024
07/11/24 Clinical Leader Newsletter
-
07.10.24 -- Does The Feasibility Process Differ For Rare Diseases Vs. Common Diseases?
7/10/2024
07/10/24 Clinical Leader Newsletter
-
07.09.24 -- The Transformative Impact Of AI On Rare Disease Research
7/9/2024
07/09/24 Clinical Leader Newsletter
-
07.08.24 -- New Law Expected To Boost Clinical Research In Brazil
7/8/2024
07/08/24 Clinical Leader Newsletter
-
07.05.24 -- Insights Into TMF Challenges & Solutions
7/5/2024
07/05/24 Clinical Leader Newsletter
This website uses cookies to ensure you get the best experience on our website. Learn more